Mehranfard, Danial and C. Speth, Robert (2022) Cholinergic anti-inflammatory pathway and COVID-19. BioImpacts.
Text
bi-12-171.pdf - Published Version
Download (1MB)
bi-12-171.pdf - Published Version
Download (1MB)
Abstract
The cholinergic anti-inflammatory pathway (CAP) first described by Wang et al, 2003 has contemporary interest arising from the COVID-19 pandemic. While tobacco smoking has been considered an aggravating factor in the severity of COVID-19 infections, it has been suggested by some that the nicotine derived from tobacco could lessen the severity of COVID-19 infections. This spotlight briefly describes the CAP and its potential role as a therapeutic target for the treatment of COVID-19 infections using vagus nerve stimulation or selective alpha7 nicotinic acetylcholine receptor agonists.
Item Type: | Article |
---|---|
Subjects: | West Bengal Archive > Medical Science |
Depositing User: | Unnamed user with email support@westbengalarchive.com |
Date Deposited: | 10 Apr 2023 06:40 |
Last Modified: | 28 Aug 2024 13:43 |
URI: | http://article.stmacademicwriting.com/id/eprint/377 |